Breaking AI & Tech News Analyzed

The CMS Pilot to Reimburse Hemp‑Derived Products The Centers for Medicare and Medicaid Services recently began a pilot that allows certain Medicare and Medicaid beneficiaries to be reimbursed for up to $500 worth of hemp‑derived products each year. The program is designed to test whether these products can lower overall health‑care costs for participants. Key Parameters of the Pilot and the Pending Hemp Ban Definition of hemp follows the 2018 Farm Bill – cannabis containing less than 0.3% delta‑9 THC. The November 12, 2026, hemp ban will make any product with more than 0.4 mg THC federally illegal. If enacted, the ban would criminalize the "vast, vast majority of hemp products, including most non‑intoxicating CBD products," according to Jonathan Miller of the US Hemp Roundtable. Legislative Efforts to Counter the Ban Lawmakers have introduced two bills aimed at either delaying or replacing the ban: Cannabinoid Safety and Regulation Act – re‑introduced by Oregon Senator Ron Wyden, proposing a regulated framework for hemp products. A two‑year delay bill – introduced by Indiana Representative Jim Baird in January. Potential Impact on Patients, Industry, and Legal Landscape If the ban takes effect, patients who rely on full‑spectrum CBD could lose access to the most therapeutically effective formulations. Small producers like Inesa Ponomariovaite of Nesa’s Hemp warn they would have to “perform plant surgery” to strip out prohibited cannabinoids, reducing product efficacy. Quality‑control concerns also surface: a recent Forbes Health investigation found mold, yeast, and fungicide in some CBD products, underscoring the need for federal oversight that the proposed safety act would enable. Legal challenges have already emerged. Advocates sued Health Secretary Robert F. Kennedy Jr. and CMS Administrator Mehmet Oz over the pilot, but the court denied the request to block the program. Outlook: Congressional Gridlock vs. Regulatory Reform Industry insiders remain "cautiously optimistic" that Congress will act before the November deadline, but deep partisan polarization makes passage uncertain. The Trump administration has signaled support for full‑spectrum CBD access, yet no concrete executive action has been announced. Should the ban be delayed or replaced, the CMS pilot could continue to generate data on cost‑saving potential, and the FDA may gain authority to enforce safety standards across the hemp market. Conversely, if the ban proceeds unchanged, the pilot could be forced to limit reimbursements to isolated CBD only, dramatically shrinking its therapeutic scope.

The Global Health Emergency DeclarationThe World Health Organization (WHO) has declared the latest Ebola outbreak in the Democratic Republic of the Congo (DRC) and neighbouring Uganda a "public health emergency of international concern" after the virus killed nearly 90 people.The outbreak, originating in eastern DRC's Ituri province, involves the rare Bundibugyo strain of Ebola. The variant has no approved vaccine or treatment, making containment particularly challenging.Health authorities said the outbreak poses a high regional risk because infections have already been detected in Uganda and cases linked to the outbreak have reached Congo's capital, Kinshasa.The WHO, however, stopped short of declaring a pandemic, saying it did not meet the necessary criteria. The United Nations agency advised countries against closing borders or restricting trade.Outbreak Origins and Current SituationThe outbreak was first reported in Ituri province in the northeastern DRC on Friday near the borders with Uganda and South Sudan, according to Africa's Centres for Disease Control and Prevention (Africa CDC). As of Saturday, the centre had reported 88 deaths and 336 suspected cases.The outbreak began in Mongwalu, a busy mining area. Infected people later travelled out of the area, sought treatment in other places and spread the disease. Africa CDC warned that population movements, weak healthcare infrastructure and violence by armed groups in Ituri could complicate containment efforts.The outbreak's patient zero was a nurse who arrived at a health facility in Ituri's capital, Bunia, on April 24, showing Ebola-like symptoms, DRC Health Minister Samuel-Roger Kamba said.Meanwhile, Uganda has recorded two laboratory-confirmed cases linked to travellers arriving from the DRC, including one death in the capital, Kampala."The number of cases and deaths we are seeing in such a short timeframe, combined with the spread across several health zones and now across the border, is extremely concerning," warned Trish Newport with the medical aid organisation Doctors Without Borders, also known by its French acronym MSF."In Ituri, many people already struggle to access healthcare and live with ongoing insecurity, making rapid action critical to prevent the outbreak from escalating further," she added.Understanding the Ebola VirusEbola is a severe and often fatal viral disease first identified in 1976 near the Ebola River in what is now the DRC. The virus is believed to originate in wild animals, particularly bats, before spreading to humans.The disease spreads through direct contact with bodily fluids such as blood, vomit, semen or other contaminated materials, including bedding and clothing. People become contagious once symptoms appear.Symptoms include fever, vomiting, diarrhoea, intense weakness, muscle pain and, in severe cases, internal and external bleeding. The incubation period can last two to 21 days.The current outbreak is caused by the Bundibugyo strain, first identified in Uganda in 2007.It has a "very high lethality rate, which can reach 50 percent", Kamba said on Saturday. "The Bundibugyo strain has no vaccine, no specific treatment," he added.Implications of the WHO Emergency DeclarationThe WHO's declaration of a "public health emergency of international concern" is the organisation's second-highest alert level under international health regulations.The agency stressed that the outbreak does not currently meet the threshold for a pandemic emergency, the highest level introduced after COVID-19. However, WHO Director-General Tedros Adhanom Ghebreyesus said neighbouring countries were "considered at high risk for further spread due to population mobility, trade and travel linkages, and ongoing epidemiological uncertainty".The organisation urged neighbouring countries to activate emergency-management systems, strengthen cross-border screening and isolate confirmed cases immediately. The WHO also recommended daily monitoring of contacts and recommended that exposed individuals avoid international travel for 21 days.At the same time, the WHO cautioned against border closures, saying restrictions could encourage unmonitored informal crossings and undermine containment efforts."There are significant uncertainties to the true number of infected persons and geographic spread associated with this event at the present time," the WHO said. "In addition, there is limited understanding of the epidemiological links with known or suspected cases."Historical Context of Ebola OutbreaksThe DRC has experienced at least 17 Ebola outbreaks since the virus was first discovered there in 1976, making it one of the countries most affected by the disease.The deadliest Ebola outbreak in the DRC occurred from 2018 to 2020 and killed nearly 2,300 people. Some cases were also reported in Uganda. Another outbreak last year killed at least 34 people before it was declared over in December.Ebola has killed about 15,000 people since it was discovered, almost all in Africa.Regional Challenges and Response DifficultiesA conflict involving several rebel groups is likely to pose a significant challenge to the response to the virus, including in Ituri province."The ongoing insecurity, humanitarian crisis, high population mobility, the urban or semiurban nature of the current hotspot and the large network of informal healthcare facilities further compound the risk of spread, as was witnessed during the large Ebola virus disease epidemic in North Kivu and Ituri provinces in 2018-19," the WHO warned.This month, an attack by rebels killed at least 69 people in the northeastern province, security officials said.The mineral-rich region faces ongoing attacks by the Allied Democratic Forces (ADF), a group formed by former Ugandan rebels that has pledged allegiance to ISIL (ISIS), and the Rwanda-backed March 23 Movement, better known as M23.For more than three decades, the eastern DRC, known for its vast mineral wealth, has been plagued by conflict as numerous armed factions compete to dominate its mining areas.

The Ebola Outbreak in DRC At least 80 deaths have been reported in the Democratic Republic of the Congo's (DRC) new Ebola disease outbreak, authorities said, as health workers race to intensify screening and contact tracing to contain the disease. The Strain and Its Implications “The Bundibugyo strain has no vaccine, no specific treatment,” DRC’s Health Minister Samuel-Roger Kamba said on Saturday. “This strain has a very high lethality rate, which can reach 50 percent.” The Outbreak Details The outbreak, the country’s seventeenth, was confirmed on Friday in the northeastern province of Ituri, which borders Uganda and South Sudan. At the time, 65 suspected deaths had been confirmed; the toll was raised to 80 on Saturday. According to Kamba, the suspected patient zero was a nurse who reported to a health facility in the provincial capital, Bunia, on April 24, with symptoms suggesting Ebola. The disease has so far been confirmed in three health zones in Ituri, including Bunia, and the areas of Rwampara and Mongwalu, where the outbreak is concentrated. The International Response Medical aid groups, including Doctors Without Borders, known by its French acronym MSF, and the International Federation of Red Cross and Red Crescent Societies (IFRC), are responding to the outbreak. “The number of cases and deaths we are seeing in such a short timeframe, combined with the spread across several health zones and now across the border, is extremely concerning,” said Trish Newport, MSF emergency programme manager. Jagan Chapagain, secretary-general of the IFRC, said, “The evolving epidemiological situation, and the risk of cross‑border spread, underscore the need for timely, coordinated and sustained action. Engaging with communities and building trust is essential to ensure people seek care early and help stop the epidemic in its tracks.” The Global Context Ebola was first identified in 1976. Three strains of the disease are responsible for the majority of outbreaks in Africa, although a vaccine exists only for the Zaire strain. Without treatment, up to 90 percent of cases can be fatal. The Bundibugyo strain, which is responsible for the current outbreak, was not identified until 2006.

Israeli forces targeted the Remal neighbourhood of Gaza City on May 15, 2026, killing Qassam Brigades commander Izz al‑Din al‑Haddad, his family members and several civilians, a strike Hamas denounced as a treacherous assassination.Israeli Strike Eliminates Qassam Brigades Chief Izz al‑Din al‑HaddadThe strike hit a residential building and a civilian vehicle, killing seven Palestinians including three women and a baby. Hamas condemned the operation as “treacherous and cowardly,” labeling al‑Haddad “one of the architects” of the October 7 attacks. Israeli Prime Minister Benjamin Netanyahu and Defence Minister Israel Katz confirmed the target was al‑Haddad.Casualty Toll and Immediate Aftermath Figures3 Palestinians killed in a civilian‑vehicle strike4 killed in the residential‑building strikeDozens wounded; 13 bodies and 57 injured patients received by Gaza hospitals in the last 24 hoursSince the October cease‑fire, Gaza Health Ministry reports 870 deaths and 2,543 injuriesEscalation Risks and Regional Political RepercussionsThe killing is portrayed by Hamas as a breach of the cease‑fire agreement and an example of “ongoing aggression against innocent civilians.” The statement warned that the “cowardly assassination” will not weaken resistance resolve. The incident also drew reactions from the Palestinian Mujahideen Movement, which vowed continued struggle.Potential Trajectories for Gaza Ceasefire and Israeli OperationsAnalysts anticipate heightened Israeli military activity as it seeks to dismantle senior Hamas leadership, while Hamas may intensify rocket fire or guerrilla attacks in retaliation. International diplomatic pressure could increase, urging both sides to return to cease‑fire talks, but the recent high‑profile killing suggests a further widening of the conflict’s scope.

The Personal Mission Behind the InvestmentReed Jobs, son of Apple co-founder Steve Jobs, is bringing his oncology-focused venture capital fund Yosemite to the UK, seeking investment opportunities in cancer care. The 34-year-old's mission is deeply personal, stemming from witnessing his father's death from a rare form of pancreatic cancer in 2011 at age 56. "I saw my dad have cancer when I was a kid, and unfortunately that happens far too often. And that really motivated me to try to transform outcomes for other people out there," Jobs explains.Yosemite's Healthcare Investment StrategyThe San Francisco-based venture fund, named after the California national park where his parents married, manages over $1 billion in assets and has already invested in approximately 20 healthcare startups. Yosemite focuses on innovative approaches to cancer treatment, including gene therapy, cancer vaccines, radiopharmaceuticals, and artificial intelligence. Notable investments include Tune Therapeutics, Azalea Therapeutics, Chai Discovery, and Sage Care in the US, with several UK companies in their portfolio that haven't been publicly announced.Financial Backing and International PartnershipsYosemite receives investment from LifeArc, a UK not-for-profit group focused on rare diseases that was established in 2000 as part of the UK's Medical Research Council. The fund also has partnerships with Oxford and Cambridge universities, where it has provided philanthropic grants. Additional backing comes from US biotech company Amgen, Massachusetts Institute of Technology, Memorial Sloan Kettering Cancer Center in New York, and billionaire investor John Doerr, following a fundraiser earlier this year.UK's Position in Global Cancer Research"Research here is world class," Jobs states during his visit to London for a life sciences conference hosted by LifeArc. The UK's strong academic institutions and research environment make it an attractive location for healthcare investment. Yosemite's international investment strategy includes the UK, where the fund aims to connect with pharmaceutical partners and academics to advance cancer treatment possibilities.Future Vision for Cancer TreatmentJobs envisions a future where cancer shifts from being an "end-stage disease" to an illness that is diagnosed early, monitored, and treated—similar to advances made with HIV and cardiovascular disease. "Today far too many cancers are either diagnosed incidentally, because there's no good early biomarker, or only diagnosed once they are metastatic and extremely advanced," he notes. The fund is particularly focused on immunotherapy, which Jobs identifies as "one of the areas I think is going to have the most promise for patients in the next couple of decades."

The LeadFalling seriously ill, like falling in love, can happen all of a sudden – although this film is not exactly about either. Ryusuke Hamaguchi's new movie, co-scripted with the Franco-Japanese screenwriter Léa Le Dimna and his first not set entirely in Japan, is a bold and high-minded if rather pedagogic work that spreads itself over three hours. It's tender and sometimes beautifully made, but also contrived and occasionally features some too-good-to-be-true caring characters. Frankly, it's rather precious.The Film's International VisionHamaguchi and Le Dimna have taken as their starting point the nonfiction book "You and I: The Illness Suddenly Get Worse" by Makiko Miyano and Maho Isono, a meditative correspondence between a philosopher and medical professional on the subjects of love and mortality. Hamaguchi has opened this out to create a drama set in Paris and Kyoto, and it's incidentally hard not to suspect that Hamaguchi, like many a celebrated movie director spending so much time on the international festival circuit, has been led to create an uneasy international mixture.Care Home Dynamics and CharactersMarie-Lou (Virginie Efira) is the director of a private care home in Paris called the Garden of Freedom, where they practise a care technique called "humanitude," a time-consuming patient-centred approach that exasperates old-fashioned nurse Sophie (Marie Bunel). It needs more staffing facilities than the home is prepared to provide and, in any case, Marie-Lou has a bad habit of being patronising to those who question her. For all that, there are some lovely scenes with caregivers and patients, and these observant, unfussily compassionate moments are where the film works best.Cross-Cultural ConnectionsMarie-Lou is stressed and overworked, and her life is upended when she encounters an autistic Japanese teen called Tomoki (Kodai Kurosaki) in the street, apparently lost; he is being looked after by his grandfather, Gorô (Kyōzō Nagatsuka), an actor in town performing in an experimental piece about psychiatric care in which Tomoki is encouraged to take part if he feels like it. The show is directed by Mari (Tao Okamoto), and her stylish calm and intelligence entrances Marie-Lou; they are clearly on the verge of an intense friendship and perhaps more, although the film is reticent on this last point.Philosophical Exchanges and Narrative ConcernsMarie-Lou comes to a performance, stays for the Q&A; afterwards and reveals herself to be fluent in Japanese, asking questions of Mari in that language which touch on Mari's very serious illness. Some in the audience rather plaintively – and understandably – call for the conversation to be in French, though this film comes close to being insufferable when Gorô solemnly tells everyone that their exchange was so intimate and meaningful that the audience should be content with simply sensing that.The Film's Strengths and WeaknessesAll of a Sudden works best entirely outside the exotically overwritten, overthought bond between Mari and Marie-Lou. The realist set pieces are very moving, showing us patients with dementia surrounded by their families, and also showing us, often with photos of their younger selves in demanding jobs, how these patients have changed. The film's high concept is a little self conscious.All of a Sudden screened at the Cannes film festival.

The Author's JourneyDoireann Ní Ghríofa, author of A Ghost in the Throat, has written a new book, Said the Dead, which delves into the history of a mental institution in Ireland. In an interview, she discusses her personal journey of recovering from depression and how it influenced her writing.Writing from ExperienceNí Ghríofa grew up in County Clare and moved to Cork for university, where she experienced severe depression and attempted to drown herself in the river on two occasions. She reflects on how her experiences have shaped her writing, particularly in her latest book.Exploring Mental Health HistoryThe book, Said the Dead, is a result of Ní Ghríofa's research into the history of a mental institution in Ireland, where she discovered the records of male and female inpatients. She shares her findings and insights into the lives of these individuals, highlighting the challenges they faced and the care they received.A Personal ConnectionNí Ghríofa's connection to the material is personal, as she reflects on her own experiences with depression and how it relates to the stories of the women she encountered in the records. She emphasizes the importance of empathy and understanding in approaching these stories.The Power of WritingThrough her writing, Ní Ghríofa aims to explore and understand the complexities of mental health and the experiences of those who have lived through it. Her book is a testament to the power of writing as a tool for healing and self-discovery.

Opening Verdict: A Darkly Comic Exploration of Dying in DevonThe Guardian’s review frames Eclipse as a stark departure from Morton’s TV work, swapping satirical bureaucracy for a family‑riven meditation on death. The play’s humor is deliberately muted, allowing the weight of an unseen cancer patient to dominate the conversation.Staging the Unseen: How Morton’s Play Brings an Off‑stage Cancer Patient to LifeSet in a convincingly lived‑in kitchen designed by Simon Higlett, the action revolves around siblings Jonathan (Rupert Penry‑Jones) and Sarah (Sarah Parish) and their husband Graham (Paul Thornley). Two nurses, Karen (Selina Cadell) and Linda (Lizzie Hopley), provide the only direct link to the off‑stage patient, Edward, whose presence is felt through dialogue rather than sight.Numbers on Stage: Cast Size, Run Length, and Box‑Office ImplicationsCast: 10 actors, with four appearing in only a single scene.Venue: Minerva Studio, Chichester Festival Theatre.Run: Until 6 June 2026 (approximately three weeks).Ticket pricing (average): £35‑£55, reflecting a mid‑range price point for a regional festival production.These figures illustrate a modest financial risk that pays off by delivering a densely populated emotional landscape within a limited budget.Why It Matters: Shifting the Tone of British Dark Comedy and Hospice NarrativeMorton pushes the envelope of British dark comedy, moving beyond the corporate satire of Twenty Twelve and W1A into a realm where laughter is eclipsed by mortality. By foregrounding the “unsaid” through hyper‑realistic speech patterns—ums, stumbles, and meaningless affirmations—the play forces audiences to confront the discomfort of hospice care and family denial.Looking Ahead: Prospects for Morton’s Theatrical Future and the Play’s Life Beyond ChichesterIf the Chichester run garners strong word‑of‑mouth, Eclipse could tour the UK regional circuit and potentially attract a West End transfer, positioning Morton as a playwright capable of handling both TV satire and serious stage drama. The production also sets a precedent for future works that blend realistic dialogue with existential themes, suggesting a broader shift in contemporary British theatre toward confronting uncomfortable social realities.

The FA's Search for a New England Manager In 2024, the Football Association tasked itself with finding Gareth Southgate's successor. To do this, they hired two external data companies to build a profile of what successful international managers looked like, then tailored it to mesh with England's player base. The Profiling Process The top 50 coaches in the world were matched against the criteria and a shortlist emerged. The FA's chief executive, Mark Bullingham, joked that the list could have been compiled in a pub in 10 minutes, but the data was valuable in seeing the relative strengths and weaknesses of each coach. The Super-Elite Category Three distinct categories emerged: coaches with high potential, 'elite' coaches achieving top results, and 'super-elite' coaches who had won big and managed top players. The FA focused on the 'super-elite' category, which included Thomas Tuchel. The Meeting with Tuchel The FA's approach to Tuchel was personal, patient, and discreet. John McDermott traveled to Munich for face-to-face discussions, where he was met with enthusiasm from Tuchel. A meeting was organized at a German airport, where the FA hired a private room and McDermott and Bullingham flew in on separate flights. Tuchel's Presentation Tuchel impressed the FA with a PowerPoint presentation on how to put a second star on the England shirt, which was well thought through and detailed. The presentation included plans for the next 18 months, how he would get the best out of players, and how he would maintain relationships.